tiprankstipranks
Advertisement
Advertisement
Entera Bio Is Building the Future of Peptides Beyond the Needle (NASDAQ: ENTX)
PremiumTipRanks NewswireEntera Bio Is Building the Future of Peptides Beyond the Needle (NASDAQ: ENTX)
28d ago
Entera Bio Faces Elevated Operational Risks Amid Escalating Middle East Geopolitical Tensions
Premium
Company Announcements
Entera Bio Faces Elevated Operational Risks Amid Escalating Middle East Geopolitical Tensions
2M ago
Entera Bio files to sell 19.57M ordinary shares for holders
Premium
The Fly
Entera Bio files to sell 19.57M ordinary shares for holders
2M ago
Entera May Be the 1st Winner of FDA’s New Framework Redefining the Multi Billion Dollar Osteoporosis Market
PremiumTipRanks NewswireEntera May Be the 1st Winner of FDA’s New Framework Redefining the Multi Billion Dollar Osteoporosis Market
3M ago
Entera Takes Final Step Towards Phase 3, Accelerating Timeline for First Oral Anabolic Osteoporosis Therapy
Premium
TipRanks Newswire
Entera Takes Final Step Towards Phase 3, Accelerating Timeline for First Oral Anabolic Osteoporosis Therapy
4M ago
Entera Bio Moves Toward Phase 3 With Oral Therapy That Could Transform Osteoporosis Treatment (NASDAQ: ENTX)
Premium
TipRanks Newswire
Entera Bio Moves Toward Phase 3 With Oral Therapy That Could Transform Osteoporosis Treatment (NASDAQ: ENTX)
4M ago
Entera Bio Names Geno Germano Independent Board Chairman
PremiumCompany AnnouncementsEntera Bio Names Geno Germano Independent Board Chairman
5M ago
Entera Bio appoints Geno Germano as chairman of the board
Premium
The Fly
Entera Bio appoints Geno Germano as chairman of the board
5M ago
Entera Bio Expands OPKO Partnership, Adds New Director
Premium
Company Announcements
Entera Bio Expands OPKO Partnership, Adds New Director
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100